Seguici
IT
IT

Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Tutte le notizie / Gennaio 2017

Archivio

✕
31 gennaio 2017
6668
The National Council of Churches in the Philippines supports condom distribution in schools

The National Council of Churches in the Philippines supports condom distribution in schools

Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV) cases are on the rise in the Philippines. To stop the spread of the virus, the Department of Health has developed a plan to distribute condoms in schools.
31 gennaio 2017
5785
Complications of advanced liver disease are on rise among HCV patients in USA

Complications of advanced liver disease are on rise among HCV patients in USA

A group of researchers from the Henry Ford Health System in Detroit, Michigan presented the results of a study regarding the complications of advance liver disease among people with chronic Hepatitis C. Findings were presented at the 2016 AASLD Liver Meeting in November.
30 gennaio 2017
6237
New laser technology for HIV diagnostic

New laser technology for HIV diagnostic

At the Society of Photo-optical Instrumentation Engineers (SPIE) West Conference the group of researchers from the Council for Scientific and Industrial Research (CSIR) will present a novel technology for laser-based HIV point-of-care diagnostics. The Conference will take ...
30 gennaio 2017
6051
Antibody administration suppresses HIV virus in HIV-infected mice

Antibody administration suppresses HIV virus in HIV-infected mice

Suppression of the HIV virus might be achieved with a new method using a combination of three antibodies. This conclusion was reported by a group of researchers at Rockefeller University. The research was conducted at the laboratory of Michel C. Nussenzweig, who is a Zanvil ...
28 gennaio 2017
6168
No new HIV Infections with Use of HIV PrEP in Northern California

No new HIV Infections with Use of HIV PrEP in Northern California

Kaiser Permanente Northern California has reported the results of a study regarding the use of preexposure prophylaxis (PrEP). Kaiser Permanente is a large integrated healthcare system that provides comprehensive medical services to more than 170 000 adults including in ...
27 gennaio 2017
5729
Limited funds to fight HIV in Russia

Limited funds to fight HIV in Russia

Recent data suggests that more than 854,000 people living in Russia today have been diagnosed with HIV and only 261,000 of them are receiving antiretroviral treatment. Despite these facts, the Russian Health Ministry has decided against allocating additional funding to ...
27 gennaio 2017
6261
NICE endorses Epclusa to use in The UK

NICE endorses Epclusa to use in The UK

It is estimated that around 214,000 people in the UK are infected with chronic Hepatitis C. A disease, if left untreated, might cause cirrhosis and liver cancer. The National Institute for Health and Care Excellence has published a guidance in which it endorsed the drug ...
26 gennaio 2017
6987
High prevalence of mental health problems among PLHIV in Nigeria

High prevalence of mental health problems among PLHIV in Nigeria

The Institute of Human Virology Nigeria (IHVN) in collaboration with the GEDE Foundation has released results of research regarding mental health issues in people living with HIV. According to it there is high prevalence of depression, suicide and alcohol abuse among People ...
26 gennaio 2017
6093
Concerns over safety of new drugs for Hepatitis C treatment have been raised

Concerns over safety of new drugs for Hepatitis C treatment have been raised

After analyzing the Food and Drug Administration’s worldwide database of reports from doctors of adverse events that might be related to medications, the Institute for Safe Medication Practices, a nonprofit in Horsham, Pa., has raised a concern about the safety of some drugs ...
25 gennaio 2017
5826
MMP and John Hopkins University signed an agreement on a drug for tuberculosis

MMP and John Hopkins University signed an agreement on a drug for tuberculosis

On January 25, 2017 The Medicines Patent Pool announced that it has signed an agreement with Johns Hopkins University to ensure the clinical development of the drug sutezolid. Sutezolid is an investigational drug to treat tuberculosis and might help to treat both drug-sensitive ...
Utilizziamo i cookie su questo sito per migliorare la tua esperienza.
Facendo clic su qualsiasi pulsante di questo sito Web, dai il tuo consenso per l'impostazione dei cookie.